Growth Metrics

Thermo Fisher Scientific (TMO) EPS (Weighted Average and Diluted) (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of EPS (Weighted Average and Diluted) readings, the most recent being $4.43 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 11.31% to $4.43 in Q1 2026 year-over-year; TTM through Mar 2026 was $18.19, a 6.69% increase, with the full-year FY2025 number at $17.74, up 7.32% from a year prior.
  • EPS (Weighted Average and Diluted) hit $4.43 in Q1 2026 for Thermo Fisher Scientific, down from $5.21 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $5.61 in Q2 2022 to a low of $3.32 in Q2 2023.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $4.22 (2022), compared with a mean of $4.22.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 16.62% in 2023, down 40.82% in 2023.
  • Thermo Fisher Scientific's EPS (Weighted Average and Diluted) stood at $4.01 in 2022, then grew by 4.74% to $4.2 in 2023, then rose by 13.81% to $4.78 in 2024, then rose by 9.0% to $5.21 in 2025, then dropped by 14.97% to $4.43 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $4.43 (Q1 2026), $5.21 (Q4 2025), and $4.27 (Q3 2025) per Business Quant data.